{"transactions":[{"id":4636386,"issuer":{"id":5607,"kind":"organization","name":"SHOULDER INNOVATIONS, INC.","symbol":"SI"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-10-06T21:05:58.000Z","date":"2026-10-05","kind":"grant","planned":false,"acquired":true,"shares":733,"price":19.6,"value":14366.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\") received in lieu of cash retainer fees, which were fully vested as of the grant date.  Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. The Reporting Person voluntarily elected to defer receipt of the Common Stock issuable upon settlement of the RSUs until the Reporting Person's departure from the Board of Directors."}],"balance_after":53445,"source":{"system":"sec-edgar","filing":"0001628280-26-065260","document":"wk-form4_1791320755.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1699350/000162828026065260/wk-form4_1791320755.xml","form_type":"4"}},{"id":4618413,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-09-15T21:07:12.000Z","date":"2025-07-24","kind":"purchase","planned":false,"acquired":true,"shares":200000,"price":15,"value":3000000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Stock held by Casey M. Tansey."}],"balance_after":200000,"source":{"system":"sec-edgar","filing":"0001193125-26-392111","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000119312526392111/ownership.xml","form_type":"4/A","original_submission_date":"2025-07-24"}},{"id":679849,"issuer":{"id":5669,"kind":"organization","name":"Mobia Medical, Inc.","symbol":"MOBI"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-21T01:05:40.000Z","date":"2026-08-18","kind":"purchase","planned":false,"acquired":true,"shares":16441,"price":12.0749,"value":198523.4309,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $11.90 to $12.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":318332,"source":{"system":"sec-edgar","filing":"0001193125-26-359683","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489993/000119312526359683/ownership.xml","form_type":"4"}},{"id":685448,"issuer":{"id":5669,"kind":"organization","name":"Mobia Medical, Inc.","symbol":"MOBI"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-18T01:53:45.000Z","date":"2026-08-17","kind":"purchase","planned":false,"acquired":true,"shares":17166,"price":11.8509,"value":203432.5494,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $11.675 to $12.37, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":301891,"source":{"system":"sec-edgar","filing":"0001193125-26-354538","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1489993/000119312526354538/ownership.xml","form_type":"4"}},{"id":685447,"issuer":{"id":5669,"kind":"organization","name":"Mobia Medical, Inc.","symbol":"MOBI"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-18T01:53:45.000Z","date":"2026-08-14","kind":"purchase","planned":false,"acquired":true,"shares":100,"price":12.53,"value":1253.0,"ownership":{"direct":true},"balance_after":284725,"source":{"system":"sec-edgar","filing":"0001193125-26-354538","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1489993/000119312526354538/ownership.xml","form_type":"4"}},{"id":685446,"issuer":{"id":5669,"kind":"organization","name":"Mobia Medical, Inc.","symbol":"MOBI"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-18T01:53:45.000Z","date":"2026-08-14","kind":"purchase","planned":false,"acquired":true,"shares":15721,"price":11.65,"value":183149.65,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $11.42 to $12.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":284625,"source":{"system":"sec-edgar","filing":"0001193125-26-354538","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1489993/000119312526354538/ownership.xml","form_type":"4"}},{"id":685445,"issuer":{"id":5669,"kind":"organization","name":"Mobia Medical, Inc.","symbol":"MOBI"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-18T01:53:45.000Z","date":"2026-08-13","kind":"purchase","planned":false,"acquired":true,"shares":35572,"price":11.5073,"value":409337.6756,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $11.33 to $11.685, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote."}],"balance_after":268904,"source":{"system":"sec-edgar","filing":"0001193125-26-354538","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489993/000119312526354538/ownership.xml","form_type":"4"}},{"id":706815,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-07-18T01:27:14.000Z","date":"2026-07-15","kind":"grant","planned":false,"acquired":true,"shares":346,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy."}],"balance_after":26632,"source":{"system":"sec-edgar","filing":"0001104659-26-084766","document":"tm2620811-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465926084766/tm2620811-3_4seq1.xml","form_type":"4"}},{"id":723938,"issuer":{"id":5607,"kind":"organization","name":"SHOULDER INNOVATIONS, INC.","symbol":"SI"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-06-29T21:56:59.000Z","date":"2026-06-26","kind":"grant","planned":false,"acquired":true,"shares":5046,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units (\"RSUs\"). The RSUs will vest on the earlier of the date of the annual meeting of stockholders to be held in 2027 or June 26, 2027. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date. The Reporting Person voluntarily elected to defer receipt of the Common Stock issuable upon settlement of the RSUs until the Reporting Person's departure from the Board of Directors."}],"balance_after":52712,"source":{"system":"sec-edgar","filing":"0001628280-26-046099","document":"wk-form4_1782770216.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000162828026046099/wk-form4_1782770216.xml","form_type":"4"}},{"id":731981,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true}}],"security":"Stock Option","published_at":"2026-06-18T21:26:00.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":16075,"price":32.05,"value":515203.75,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on the earlier of the day prior to Heartflow's annual meeting of shareholders in 2027 and the first anniversary of the grant date, subject to continued service through such date."}],"balance_after":16075,"derivative":{"exercise_price":32.05,"expiration_date":"2036-06-16","underlying":"Common Stock","underlying_shares":16075},"source":{"system":"sec-edgar","filing":"0001464521-26-000085","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000146452126000085/form4.xml","form_type":"4"}},{"id":784727,"issuer":{"id":5669,"kind":"organization","name":"Mobia Medical, Inc.","symbol":"MOBI"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E-2 Preferred Stock","published_at":"2026-05-12T01:58:21.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":5895530,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"After the transactions reported herein, includes (i) 1,623,245 shares of Common Stock held by U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\") on its own behalf and as a nominee for U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\" and, together with USVP SFI, the \"USVP Select Funds\"), (ii) 1,906,809 shares of Common Stock held by U.S. Venture Partners XII, L.P. (\"USVP XII\"), and (iii) 96,772 shares of Common Stock  held by U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\" and, together with USVP XII, the \"USVP XII Funds\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C. (\"PMG XII\") is the general partner of USVP XII and USVP XII-A and may be deemed to have sole voting and dispositive power with respect to the shares held by USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C. (\"PMG Select\") is the general partner of USVP SFI and USVP SFI-A and may be deemed to have sole voting and dispositive power with respect to the securites held by USVP SFI and USVP SFI-A."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Reporting Person is the managing partner and a managing member of each of PMG XII and PMG Select, and may be deemed to share voting and dispositive power with respect to the securites described herein. The Reporting Person disclaims beneficial ownership of such holdings, except to the extent of his pecuniary interest in the shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1692658},"source":{"system":"sec-edgar","filing":"0001628280-26-033820","document":"wk-form4_1778551097.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1489993/000162828026033820/wk-form4_1778551097.xml","form_type":"4"}},{"id":784726,"issuer":{"id":5669,"kind":"organization","name":"Mobia Medical, Inc.","symbol":"MOBI"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series F Preferred Stock","published_at":"2026-05-12T01:58:21.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":5642738,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"After the transactions reported herein, includes (i) 1,623,245 shares of Common Stock held by U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\") on its own behalf and as a nominee for U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\" and, together with USVP SFI, the \"USVP Select Funds\"), (ii) 1,906,809 shares of Common Stock held by U.S. Venture Partners XII, L.P. (\"USVP XII\"), and (iii) 96,772 shares of Common Stock  held by U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\" and, together with USVP XII, the \"USVP XII Funds\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C. (\"PMG XII\") is the general partner of USVP XII and USVP XII-A and may be deemed to have sole voting and dispositive power with respect to the shares held by USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C. (\"PMG Select\") is the general partner of USVP SFI and USVP SFI-A and may be deemed to have sole voting and dispositive power with respect to the securites held by USVP SFI and USVP SFI-A."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Reporting Person is the managing partner and a managing member of each of PMG XII and PMG Select, and may be deemed to share voting and dispositive power with respect to the securites described herein. The Reporting Person disclaims beneficial ownership of such holdings, except to the extent of his pecuniary interest in the shares."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1620078},"source":{"system":"sec-edgar","filing":"0001628280-26-033820","document":"wk-form4_1778551097.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1489993/000162828026033820/wk-form4_1778551097.xml","form_type":"4"}},{"id":784725,"issuer":{"id":5669,"kind":"organization","name":"Mobia Medical, Inc.","symbol":"MOBI"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Notes","published_at":"2026-05-12T01:58:21.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":2000000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"Offering\"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"Offering\"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"Offering\"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"Offering\"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":166666},"source":{"system":"sec-edgar","filing":"0001628280-26-033820","document":"wk-form4_1778551097.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1489993/000162828026033820/wk-form4_1778551097.xml","form_type":"4"}},{"id":784724,"issuer":{"id":5669,"kind":"organization","name":"Mobia Medical, Inc.","symbol":"MOBI"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Notes","published_at":"2026-05-12T01:58:21.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":false,"shares":3769090.08,"ownership":{"direct":false,"nature":"By U.S. Venture Partners Select Fund I, L.P"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"Offering\"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"Offering\"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"Offering\"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"Offering\"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":314090},"source":{"system":"sec-edgar","filing":"0001628280-26-033820","document":"wk-form4_1778551097.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1489993/000162828026033820/wk-form4_1778551097.xml","form_type":"4"}},{"id":784723,"issuer":{"id":5669,"kind":"organization","name":"Mobia Medical, Inc.","symbol":"MOBI"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option","published_at":"2026-05-12T01:58:21.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":31520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The stock option will vest in three substantially equal installments on the first three anniversaries of the grant date."}],"balance_after":31520,"derivative":{"exercise_price":15,"expiration_date":"2026-05-07","underlying":"Common Stock","underlying_shares":31520},"source":{"system":"sec-edgar","filing":"0001628280-26-033820","document":"wk-form4_1778551097.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1489993/000162828026033820/wk-form4_1778551097.xml","form_type":"4"}},{"id":784722,"issuer":{"id":5669,"kind":"organization","name":"Mobia Medical, Inc.","symbol":"MOBI"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Notes","published_at":"2026-05-12T01:58:21.000Z","date":"2026-02-10","kind":"grant","planned":false,"acquired":true,"shares":2000000,"price":2000000,"value":4000000000000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"Offering\"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes."},{"field":"date","element":"transactionDate","label":"F6","text":"This transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Offering, and is reported herein pursuant to Rule 16a-2(a)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"Offering\"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"Offering\"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes."}],"balance_after":2000000,"derivative":{"underlying":"Common Stock","underlying_shares":166666},"source":{"system":"sec-edgar","filing":"0001628280-26-033820","document":"wk-form4_1778551097.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1489993/000162828026033820/wk-form4_1778551097.xml","form_type":"4"}},{"id":784721,"issuer":{"id":5669,"kind":"organization","name":"Mobia Medical, Inc.","symbol":"MOBI"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Notes","published_at":"2026-05-12T01:58:21.000Z","date":"2026-02-06","kind":"grant","planned":false,"acquired":true,"shares":3769090.08,"price":3769090.08,"value":14206040031154.406,"ownership":{"direct":false,"nature":"By U.S. Venture Partners Select Fund I, L.P"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"Offering\"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes."},{"field":"date","element":"transactionDate","label":"F6","text":"This transaction occurred prior to the Issuer's registration of a class of equity securities under Section 12 of the Securities Exchange Act of 1934, as amended, in connection with the Offering, and is reported herein pursuant to Rule 16a-2(a)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"Offering\"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"Offering\"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes."}],"balance_after":3769090.08,"derivative":{"underlying":"Common Stock","underlying_shares":314090},"source":{"system":"sec-edgar","filing":"0001628280-26-033820","document":"wk-form4_1778551097.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1489993/000162828026033820/wk-form4_1778551097.xml","form_type":"4"}},{"id":784720,"issuer":{"id":5669,"kind":"organization","name":"Mobia Medical, Inc.","symbol":"MOBI"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T01:58:21.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":true,"shares":3312736,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Each share of the Series F Preferred Stock and Series E-2 Preferred Stock converted into Common Stock immediately prior to the completion of the Offering pursuant to its terms."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"After the transactions reported herein, includes (i) 1,623,245 shares of Common Stock held by U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\") on its own behalf and as a nominee for U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\" and, together with USVP SFI, the \"USVP Select Funds\"), (ii) 1,906,809 shares of Common Stock held by U.S. Venture Partners XII, L.P. (\"USVP XII\"), and (iii) 96,772 shares of Common Stock  held by U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\" and, together with USVP XII, the \"USVP XII Funds\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C. (\"PMG XII\") is the general partner of USVP XII and USVP XII-A and may be deemed to have sole voting and dispositive power with respect to the shares held by USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C. (\"PMG Select\") is the general partner of USVP SFI and USVP SFI-A and may be deemed to have sole voting and dispositive power with respect to the securites held by USVP SFI and USVP SFI-A."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Reporting Person is the managing partner and a managing member of each of PMG XII and PMG Select, and may be deemed to share voting and dispositive power with respect to the securites described herein. The Reporting Person disclaims beneficial ownership of such holdings, except to the extent of his pecuniary interest in the shares."}],"balance_after":3626826,"source":{"system":"sec-edgar","filing":"0001628280-26-033820","document":"wk-form4_1778551097.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1489993/000162828026033820/wk-form4_1778551097.xml","form_type":"4"}},{"id":784719,"issuer":{"id":5669,"kind":"organization","name":"Mobia Medical, Inc.","symbol":"MOBI"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T01:58:21.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":true,"shares":314090,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"Offering\"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"After the transactions reported herein, includes (i) 1,623,245 shares of Common Stock held by U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\") on its own behalf and as a nominee for U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\" and, together with USVP SFI, the \"USVP Select Funds\"), (ii) 1,906,809 shares of Common Stock held by U.S. Venture Partners XII, L.P. (\"USVP XII\"), and (iii) 96,772 shares of Common Stock  held by U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\" and, together with USVP XII, the \"USVP XII Funds\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C. (\"PMG XII\") is the general partner of USVP XII and USVP XII-A and may be deemed to have sole voting and dispositive power with respect to the shares held by USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C. (\"PMG Select\") is the general partner of USVP SFI and USVP SFI-A and may be deemed to have sole voting and dispositive power with respect to the securites held by USVP SFI and USVP SFI-A."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"The Reporting Person is the managing partner and a managing member of each of PMG XII and PMG Select, and may be deemed to share voting and dispositive power with respect to the securites described herein. The Reporting Person disclaims beneficial ownership of such holdings, except to the extent of his pecuniary interest in the shares."}],"balance_after":314090,"source":{"system":"sec-edgar","filing":"0001628280-26-033820","document":"wk-form4_1778551097.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1489993/000162828026033820/wk-form4_1778551097.xml","form_type":"4"}},{"id":784718,"issuer":{"id":5669,"kind":"organization","name":"Mobia Medical, Inc.","symbol":"MOBI"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T01:58:21.000Z","date":"2026-05-11","kind":"purchase","planned":false,"acquired":true,"shares":66666,"price":15,"value":999990.0,"ownership":{"direct":true},"balance_after":233332,"source":{"system":"sec-edgar","filing":"0001628280-26-033820","document":"wk-form4_1778551097.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1489993/000162828026033820/wk-form4_1778551097.xml","form_type":"4"}},{"id":784717,"issuer":{"id":5669,"kind":"organization","name":"Mobia Medical, Inc.","symbol":"MOBI"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-05-12T01:58:21.000Z","date":"2026-05-11","kind":"exercise","planned":false,"acquired":true,"shares":166666,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The Convertible Notes automatically converted into Common Stock immediately prior to the closing of the Issuer's initial public offering (the \"Offering\"). The conversion price is the lower of (a) 80% of the Offering price per share and (b) the valuation of the Issuer immediately prior to the closing of the Offering divided by the number of fully diluted shares of capital stock (on an as-converted basis) outstanding immediately prior to Offering, excluding the Convertible Notes."}],"balance_after":166666,"source":{"system":"sec-edgar","filing":"0001628280-26-033820","document":"wk-form4_1778551097.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1489993/000162828026033820/wk-form4_1778551097.xml","form_type":"4"}},{"id":793817,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-05-04T22:24:44.000Z","date":"2026-04-30","kind":"grant","planned":false,"acquired":true,"shares":3562,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary service with the Issuer through the applicable vesting date."}],"balance_after":26286,"source":{"system":"sec-edgar","filing":"0001104659-26-055064","document":"tm2613528-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465926055064/tm2613528-6_4seq1.xml","form_type":"4"}},{"id":807025,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-04-16T20:05:22.000Z","date":"2026-04-15","kind":"grant","planned":false,"acquired":true,"shares":308,"price":52.07,"value":16037.56,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy."}],"balance_after":22724,"source":{"system":"sec-edgar","filing":"0001104659-26-044359","document":"tm2612028-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465926044359/tm2612028-1_4seq1.xml","form_type":"4"}},{"id":935362,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-01-20T21:05:14.000Z","date":"2026-01-15","kind":"grant","planned":false,"acquired":true,"shares":181,"price":96.47,"value":17461.07,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy."}],"balance_after":22416,"source":{"system":"sec-edgar","filing":"0001104659-26-005027","document":"tm263634-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465926005027/tm263634-1_4seq1.xml","form_type":"4"}},{"id":1017580,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-10-16T20:15:47.000Z","date":"2025-10-14","kind":"grant","planned":false,"acquired":true,"shares":221,"price":78.84,"value":17423.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy."}],"balance_after":22235,"source":{"system":"sec-edgar","filing":"0001104659-25-100095","document":"tm2528856-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465925100095/tm2528856-3_4seq1.xml","form_type":"4"}},{"id":1070120,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2025-08-12T01:00:45.000Z","date":"2025-08-07","kind":"grant","planned":false,"acquired":true,"shares":47420,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The option will vest in full on the earlier of Heartflow's annual meeting of shareholders in 2026 and the first anniversary of the grant date, subject to continued service through such date."}],"balance_after":47420,"derivative":{"exercise_price":19,"expiration_date":"2035-08-07","underlying":"Common Stock","underlying_shares":47420},"source":{"system":"sec-edgar","filing":"0001628280-25-039730","document":"wk-form4_1754960439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":23,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000162828025039730/wk-form4_1754960439.xml","form_type":"4"}},{"id":1070119,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2025-08-12T01:00:45.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":false,"shares":16447,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Upon the closing of Heartflow's initial public offering, the convertible promissory notes automatically converted into shares of Heartflow's common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. The shares of common stock that were issuable upon conversion of the convertible promissory note had no expiration date. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Upon the closing of Heartflow's initial public offering, the convertible promissory notes automatically converted into shares of Heartflow's common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. The shares of common stock that were issuable upon conversion of the convertible promissory note had no expiration date. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Upon the closing of Heartflow's initial public offering, the convertible promissory notes automatically converted into shares of Heartflow's common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. The shares of common stock that were issuable upon conversion of the convertible promissory note had no expiration date. These shares are reported in Table II above on an as-converted basis."}],"balance_after":0,"derivative":{"exercise_price":15.2,"underlying":"Common Stock","underlying_shares":16447},"source":{"system":"sec-edgar","filing":"0001628280-25-039730","document":"wk-form4_1754960439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":22,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000162828025039730/wk-form4_1754960439.xml","form_type":"4"}},{"id":1070118,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2025-08-12T01:00:45.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":false,"shares":1655,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By USVP X Affiliates, L.P."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Upon the closing of Heartflow's initial public offering, the convertible promissory notes automatically converted into shares of Heartflow's common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. The shares of common stock that were issuable upon conversion of the convertible promissory note had no expiration date. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Upon the closing of Heartflow's initial public offering, the convertible promissory notes automatically converted into shares of Heartflow's common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. The shares of common stock that were issuable upon conversion of the convertible promissory note had no expiration date. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Upon the closing of Heartflow's initial public offering, the convertible promissory notes automatically converted into shares of Heartflow's common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. The shares of common stock that were issuable upon conversion of the convertible promissory note had no expiration date. These shares are reported in Table II above on an as-converted basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group X, L.L.C. (\"PMG X\") is the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. The Reporting Person, Steven M. Krausz, Richard W. Lewis, Jonathan D. Root and Irwin Federman are the managing members of PMG X, and share voting and dispositive power with respect to the shares held by U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. Each of the managing members of PMG X disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":15.2,"underlying":"Common Stock","underlying_shares":1655},"source":{"system":"sec-edgar","filing":"0001628280-25-039730","document":"wk-form4_1754960439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":21,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000162828025039730/wk-form4_1754960439.xml","form_type":"4"}},{"id":1070117,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Convertible Promissory Note","published_at":"2025-08-12T01:00:45.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":false,"shares":51736,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By U.S. Venture Partners X, L.P."},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Upon the closing of Heartflow's initial public offering, the convertible promissory notes automatically converted into shares of Heartflow's common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. The shares of common stock that were issuable upon conversion of the convertible promissory note had no expiration date. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Upon the closing of Heartflow's initial public offering, the convertible promissory notes automatically converted into shares of Heartflow's common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. The shares of common stock that were issuable upon conversion of the convertible promissory note had no expiration date. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Upon the closing of Heartflow's initial public offering, the convertible promissory notes automatically converted into shares of Heartflow's common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. The shares of common stock that were issuable upon conversion of the convertible promissory note had no expiration date. These shares are reported in Table II above on an as-converted basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group X, L.L.C. (\"PMG X\") is the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. The Reporting Person, Steven M. Krausz, Richard W. Lewis, Jonathan D. Root and Irwin Federman are the managing members of PMG X, and share voting and dispositive power with respect to the shares held by U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. Each of the managing members of PMG X disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"exercise_price":15.2,"underlying":"Common Stock","underlying_shares":51736},"source":{"system":"sec-edgar","filing":"0001628280-25-039730","document":"wk-form4_1754960439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":20,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000162828025039730/wk-form4_1754960439.xml","form_type":"4"}},{"id":1070116,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series F Preferred Stock","published_at":"2025-08-12T01:00:45.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":false,"shares":37244,"ownership":{"direct":false,"nature":"By USVP X Affiliates, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each share of Series F preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"shares","element":"transactionShares","label":"F4","text":"Each share of Series F preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of Series F preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of Series F preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of Series F preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group X, L.L.C. (\"PMG X\") is the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. The Reporting Person, Steven M. Krausz, Richard W. Lewis, Jonathan D. Root and Irwin Federman are the managing members of PMG X, and share voting and dispositive power with respect to the shares held by U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. Each of the managing members of PMG X disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":37244},"source":{"system":"sec-edgar","filing":"0001628280-25-039730","document":"wk-form4_1754960439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":19,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000162828025039730/wk-form4_1754960439.xml","form_type":"4"}},{"id":1070115,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series F Preferred Stock","published_at":"2025-08-12T01:00:45.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":false,"shares":1164179,"ownership":{"direct":false,"nature":"By U.S. Venture Partners X, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each share of Series F preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"shares","element":"transactionShares","label":"F4","text":"Each share of Series F preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of Series F preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of Series F preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of Series F preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group X, L.L.C. (\"PMG X\") is the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. The Reporting Person, Steven M. Krausz, Richard W. Lewis, Jonathan D. Root and Irwin Federman are the managing members of PMG X, and share voting and dispositive power with respect to the shares held by U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. Each of the managing members of PMG X disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1164179},"source":{"system":"sec-edgar","filing":"0001628280-25-039730","document":"wk-form4_1754960439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000162828025039730/wk-form4_1754960439.xml","form_type":"4"}},{"id":1070114,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series D Preferred Stock","published_at":"2025-08-12T01:00:45.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":false,"shares":2586,"ownership":{"direct":false,"nature":"By USVP X Affiliates, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group X, L.L.C. (\"PMG X\") is the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. The Reporting Person, Steven M. Krausz, Richard W. Lewis, Jonathan D. Root and Irwin Federman are the managing members of PMG X, and share voting and dispositive power with respect to the shares held by U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. Each of the managing members of PMG X disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2586},"source":{"system":"sec-edgar","filing":"0001628280-25-039730","document":"wk-form4_1754960439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000162828025039730/wk-form4_1754960439.xml","form_type":"4"}},{"id":1070113,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series D Preferred Stock","published_at":"2025-08-12T01:00:45.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":false,"shares":323,"ownership":{"direct":false,"nature":"By USVP X Affiliates, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group X, L.L.C. (\"PMG X\") is the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. The Reporting Person, Steven M. Krausz, Richard W. Lewis, Jonathan D. Root and Irwin Federman are the managing members of PMG X, and share voting and dispositive power with respect to the shares held by U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. Each of the managing members of PMG X disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":323},"source":{"system":"sec-edgar","filing":"0001628280-25-039730","document":"wk-form4_1754960439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000162828025039730/wk-form4_1754960439.xml","form_type":"4"}},{"id":1070112,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series D Preferred Stock","published_at":"2025-08-12T01:00:45.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":false,"shares":80855,"ownership":{"direct":false,"nature":"By U.S. Venture Partners X, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group X, L.L.C. (\"PMG X\") is the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. The Reporting Person, Steven M. Krausz, Richard W. Lewis, Jonathan D. Root and Irwin Federman are the managing members of PMG X, and share voting and dispositive power with respect to the shares held by U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. Each of the managing members of PMG X disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":80855},"source":{"system":"sec-edgar","filing":"0001628280-25-039730","document":"wk-form4_1754960439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000162828025039730/wk-form4_1754960439.xml","form_type":"4"}},{"id":1070111,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series D Preferred Stock","published_at":"2025-08-12T01:00:45.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":false,"shares":10106,"ownership":{"direct":false,"nature":"By U.S. Venture Partners X, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"shares","element":"transactionShares","label":"F3","text":"Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group X, L.L.C. (\"PMG X\") is the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. The Reporting Person, Steven M. Krausz, Richard W. Lewis, Jonathan D. Root and Irwin Federman are the managing members of PMG X, and share voting and dispositive power with respect to the shares held by U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. Each of the managing members of PMG X disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10106},"source":{"system":"sec-edgar","filing":"0001628280-25-039730","document":"wk-form4_1754960439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000162828025039730/wk-form4_1754960439.xml","form_type":"4"}},{"id":1070110,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2025-08-12T01:00:45.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":false,"shares":21295,"ownership":{"direct":false,"nature":"By USVP X Affiliates, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group X, L.L.C. (\"PMG X\") is the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. The Reporting Person, Steven M. Krausz, Richard W. Lewis, Jonathan D. Root and Irwin Federman are the managing members of PMG X, and share voting and dispositive power with respect to the shares held by U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. Each of the managing members of PMG X disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":21295},"source":{"system":"sec-edgar","filing":"0001628280-25-039730","document":"wk-form4_1754960439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000162828025039730/wk-form4_1754960439.xml","form_type":"4"}},{"id":1070109,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2025-08-12T01:00:45.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":false,"shares":665623,"ownership":{"direct":false,"nature":"By U.S. Venture Partners X, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group X, L.L.C. (\"PMG X\") is the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. The Reporting Person, Steven M. Krausz, Richard W. Lewis, Jonathan D. Root and Irwin Federman are the managing members of PMG X, and share voting and dispositive power with respect to the shares held by U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. Each of the managing members of PMG X disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":665623},"source":{"system":"sec-edgar","filing":"0001628280-25-039730","document":"wk-form4_1754960439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000162828025039730/wk-form4_1754960439.xml","form_type":"4"}},{"id":1070108,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B-2 Preferred Stock","published_at":"2025-08-12T01:00:45.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":false,"shares":7040,"ownership":{"direct":false,"nature":"By USVP X Affiliates,  L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"shares","element":"transactionShares","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group X, L.L.C. (\"PMG X\") is the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. The Reporting Person, Steven M. Krausz, Richard W. Lewis, Jonathan D. Root and Irwin Federman are the managing members of PMG X, and share voting and dispositive power with respect to the shares held by U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. Each of the managing members of PMG X disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7040},"source":{"system":"sec-edgar","filing":"0001628280-25-039730","document":"wk-form4_1754960439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000162828025039730/wk-form4_1754960439.xml","form_type":"4"}},{"id":1070107,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B-2 Preferred Stock","published_at":"2025-08-12T01:00:45.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":false,"shares":10560,"ownership":{"direct":false,"nature":"By USVP X Affiliates, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"shares","element":"transactionShares","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group X, L.L.C. (\"PMG X\") is the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. The Reporting Person, Steven M. Krausz, Richard W. Lewis, Jonathan D. Root and Irwin Federman are the managing members of PMG X, and share voting and dispositive power with respect to the shares held by U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. Each of the managing members of PMG X disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10560},"source":{"system":"sec-edgar","filing":"0001628280-25-039730","document":"wk-form4_1754960439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000162828025039730/wk-form4_1754960439.xml","form_type":"4"}},{"id":1070106,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B-2 Preferred Stock","published_at":"2025-08-12T01:00:45.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":false,"shares":330078,"ownership":{"direct":false,"nature":"By U.S. Venture Partners X, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"shares","element":"transactionShares","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group X, L.L.C. (\"PMG X\") is the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. The Reporting Person, Steven M. Krausz, Richard W. Lewis, Jonathan D. Root and Irwin Federman are the managing members of PMG X, and share voting and dispositive power with respect to the shares held by U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. Each of the managing members of PMG X disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":330078},"source":{"system":"sec-edgar","filing":"0001628280-25-039730","document":"wk-form4_1754960439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000162828025039730/wk-form4_1754960439.xml","form_type":"4"}},{"id":1070105,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B-2 Preferred Stock","published_at":"2025-08-12T01:00:45.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":false,"shares":220052,"ownership":{"direct":false,"nature":"By U.S. Venture Partners X, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"shares","element":"transactionShares","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group X, L.L.C. (\"PMG X\") is the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. The Reporting Person, Steven M. Krausz, Richard W. Lewis, Jonathan D. Root and Irwin Federman are the managing members of PMG X, and share voting and dispositive power with respect to the shares held by U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. Each of the managing members of PMG X disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":220052},"source":{"system":"sec-edgar","filing":"0001628280-25-039730","document":"wk-form4_1754960439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000162828025039730/wk-form4_1754960439.xml","form_type":"4"}},{"id":1070104,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2025-08-12T01:00:45.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":false,"shares":7040,"ownership":{"direct":false,"nature":"By USVP X Affiliates,  L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"shares","element":"transactionShares","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group X, L.L.C. (\"PMG X\") is the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. The Reporting Person, Steven M. Krausz, Richard W. Lewis, Jonathan D. Root and Irwin Federman are the managing members of PMG X, and share voting and dispositive power with respect to the shares held by U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. Each of the managing members of PMG X disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7040},"source":{"system":"sec-edgar","filing":"0001628280-25-039730","document":"wk-form4_1754960439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000162828025039730/wk-form4_1754960439.xml","form_type":"4"}},{"id":1070103,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2025-08-12T01:00:45.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":false,"shares":10560,"ownership":{"direct":false,"nature":"By USVP X Affiliates, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"shares","element":"transactionShares","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group X, L.L.C. (\"PMG X\") is the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. The Reporting Person, Steven M. Krausz, Richard W. Lewis, Jonathan D. Root and Irwin Federman are the managing members of PMG X, and share voting and dispositive power with respect to the shares held by U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. Each of the managing members of PMG X disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":10560},"source":{"system":"sec-edgar","filing":"0001628280-25-039730","document":"wk-form4_1754960439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000162828025039730/wk-form4_1754960439.xml","form_type":"4"}},{"id":1070102,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2025-08-12T01:00:45.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":false,"shares":330078,"ownership":{"direct":false,"nature":"By U.S. Venture Partners X, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"shares","element":"transactionShares","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group X, L.L.C. (\"PMG X\") is the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. The Reporting Person, Steven M. Krausz, Richard W. Lewis, Jonathan D. Root and Irwin Federman are the managing members of PMG X, and share voting and dispositive power with respect to the shares held by U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. Each of the managing members of PMG X disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":330078},"source":{"system":"sec-edgar","filing":"0001628280-25-039730","document":"wk-form4_1754960439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000162828025039730/wk-form4_1754960439.xml","form_type":"4"}},{"id":1070101,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B-1 Preferred Stock","published_at":"2025-08-12T01:00:45.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":false,"shares":220052,"ownership":{"direct":false,"nature":"By U.S. Venture Partners X, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"shares","element":"transactionShares","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group X, L.L.C. (\"PMG X\") is the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. The Reporting Person, Steven M. Krausz, Richard W. Lewis, Jonathan D. Root and Irwin Federman are the managing members of PMG X, and share voting and dispositive power with respect to the shares held by U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. Each of the managing members of PMG X disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":220052},"source":{"system":"sec-edgar","filing":"0001628280-25-039730","document":"wk-form4_1754960439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000162828025039730/wk-form4_1754960439.xml","form_type":"4"}},{"id":1070100,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-12T01:00:45.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":true,"shares":16447,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Upon the closing of Heartflow's initial public offering, the convertible promissory notes automatically converted into shares of Heartflow's common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. The shares of common stock that were issuable upon conversion of the convertible promissory note had no expiration date. These shares are reported in Table II above on an as-converted basis."}],"balance_after":16447,"source":{"system":"sec-edgar","filing":"0001628280-25-039730","document":"wk-form4_1754960439.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000162828025039730/wk-form4_1754960439.xml","form_type":"4"}},{"id":1070099,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-12T01:00:45.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":true,"shares":98303,"ownership":{"direct":false,"nature":"By USVP X Affiliates, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of Series F preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Upon the closing of Heartflow's initial public offering, the convertible promissory notes automatically converted into shares of Heartflow's common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. The shares of common stock that were issuable upon conversion of the convertible promissory note had no expiration date. These shares are reported in Table II above on an as-converted basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group X, L.L.C. (\"PMG X\") is the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. The Reporting Person, Steven M. Krausz, Richard W. Lewis, Jonathan D. Root and Irwin Federman are the managing members of PMG X, and share voting and dispositive power with respect to the shares held by U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. Each of the managing members of PMG X disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":98303,"source":{"system":"sec-edgar","filing":"0001628280-25-039730","document":"wk-form4_1754960439.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000162828025039730/wk-form4_1754960439.xml","form_type":"4"}},{"id":1070098,"issuer":{"id":3993,"kind":"organization","name":"Heartflow, Inc.","symbol":"HTFL"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-12T01:00:45.000Z","date":"2025-08-11","kind":"exercise","planned":false,"acquired":true,"shares":3072759,"ownership":{"direct":false,"nature":"By U.S. Venture Partners X, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series B-1 preferred stock and Series B-2 preferred stock automatically converted into approximately 0.4031 shares of Heartflow, Inc.'s (\"Heartflow\") common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series C preferred stock automatically converted into approximately 0.5764 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series D preferred stock automatically converted into approximately 0.6467 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of Series F preferred stock automatically converted into approximately 0.3425 shares of Heartflow's common stock immediately prior to the closing of Heartflow's initial public offering. These shares are reported in Table II above on an as-converted basis."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Upon the closing of Heartflow's initial public offering, the convertible promissory notes automatically converted into shares of Heartflow's common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. The shares of common stock that were issuable upon conversion of the convertible promissory note had no expiration date. These shares are reported in Table II above on an as-converted basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Presidio Management Group X, L.L.C. (\"PMG X\") is the general partner of U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. The Reporting Person, Steven M. Krausz, Richard W. Lewis, Jonathan D. Root and Irwin Federman are the managing members of PMG X, and share voting and dispositive power with respect to the shares held by U.S. Venture Partners X, L.P. and USVP X Affiliates, L.P. Each of the managing members of PMG X disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose."}],"balance_after":3072759,"source":{"system":"sec-edgar","filing":"0001628280-25-039730","document":"wk-form4_1754960439.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000162828025039730/wk-form4_1754960439.xml","form_type":"4"}},{"id":1074432,"issuer":{"id":5607,"kind":"organization","name":"SHOULDER INNOVATIONS, INC.","symbol":"SI"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series E Convertible Preferred Stock","published_at":"2025-08-05T20:05:09.000Z","date":"2025-08-01","kind":"exercise","planned":false,"acquired":false,"shares":20504376,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group XII, L.L.C. (\"PMG XII\") is the general partner of U.S. Venture Partners XII, L.P. (\"USVP XII\") and U.S. Venture Partners XII-A, L.P (\"USVP XII-A\") and has sole voting and dispositive power with respect to the shares held by USVP XII and USVP XII-A. The Reporting Person, Steven M. Krausz, Richard W. Lewis, Jonathan D. Root and Dafina Toncheva are the managing members of PMG XII, and share voting and dispositive power with respect to the shares held by USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C. (\"PMG Select\") is the general partner of U.S. Venture Partners Select Fund I-A, L.P. (\"USVP Select\") and has sole voting and dispositive power with respect to the shares held by USVP Select."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person, Richard W. Lewis, Jonathan D. Root and Dafina Toncheva are the managing members of PMG Select and share voting and dispositive power with respect to the shares held by USVP Select. Each of the managing members of PMG XII and PMG Select disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Consists of (i) 1,043,988 shares of Common Stock underlying Series C Preferred Stock, 496,309 shares of Common Stock underlying Series D Preferred Stock and 146,106 shares of Common Stock underlying Series E Preferred Stock held by USVP XII; (ii) 52,983 shares of Common Stock underlying Series C Preferred Stock, 25,189 shares of Common Stock underlying Series D Preferred Stock, and 7,415 shares of Common Stock underlying Series E Preferred Stock held by USVP XII-A; and (iii) 921,131 shares of Common Stock underlying Series E Preferred Stock held by U.S. Venture Partners Select Fund I, L.P. on its own behalf and as a nominee for USVP Select."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1074652},"source":{"system":"sec-edgar","filing":"0001641172-25-022252","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000164117225022252/ownership.xml","form_type":"4"}},{"id":1074431,"issuer":{"id":5607,"kind":"organization","name":"SHOULDER INNOVATIONS, INC.","symbol":"SI"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2025-08-05T20:05:09.000Z","date":"2025-08-01","kind":"exercise","planned":false,"acquired":false,"shares":9950208,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group XII, L.L.C. (\"PMG XII\") is the general partner of U.S. Venture Partners XII, L.P. (\"USVP XII\") and U.S. Venture Partners XII-A, L.P (\"USVP XII-A\") and has sole voting and dispositive power with respect to the shares held by USVP XII and USVP XII-A. The Reporting Person, Steven M. Krausz, Richard W. Lewis, Jonathan D. Root and Dafina Toncheva are the managing members of PMG XII, and share voting and dispositive power with respect to the shares held by USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C. (\"PMG Select\") is the general partner of U.S. Venture Partners Select Fund I-A, L.P. (\"USVP Select\") and has sole voting and dispositive power with respect to the shares held by USVP Select."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person, Richard W. Lewis, Jonathan D. Root and Dafina Toncheva are the managing members of PMG Select and share voting and dispositive power with respect to the shares held by USVP Select. Each of the managing members of PMG XII and PMG Select disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Consists of (i) 1,043,988 shares of Common Stock underlying Series C Preferred Stock, 496,309 shares of Common Stock underlying Series D Preferred Stock and 146,106 shares of Common Stock underlying Series E Preferred Stock held by USVP XII; (ii) 52,983 shares of Common Stock underlying Series C Preferred Stock, 25,189 shares of Common Stock underlying Series D Preferred Stock, and 7,415 shares of Common Stock underlying Series E Preferred Stock held by USVP XII-A; and (iii) 921,131 shares of Common Stock underlying Series E Preferred Stock held by U.S. Venture Partners Select Fund I, L.P. on its own behalf and as a nominee for USVP Select."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":521498},"source":{"system":"sec-edgar","filing":"0001641172-25-022252","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000164117225022252/ownership.xml","form_type":"4"}},{"id":1074430,"issuer":{"id":5607,"kind":"organization","name":"SHOULDER INNOVATIONS, INC.","symbol":"SI"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2025-08-05T20:05:09.000Z","date":"2025-08-01","kind":"exercise","planned":false,"acquired":false,"shares":20930233,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group XII, L.L.C. (\"PMG XII\") is the general partner of U.S. Venture Partners XII, L.P. (\"USVP XII\") and U.S. Venture Partners XII-A, L.P (\"USVP XII-A\") and has sole voting and dispositive power with respect to the shares held by USVP XII and USVP XII-A. The Reporting Person, Steven M. Krausz, Richard W. Lewis, Jonathan D. Root and Dafina Toncheva are the managing members of PMG XII, and share voting and dispositive power with respect to the shares held by USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C. (\"PMG Select\") is the general partner of U.S. Venture Partners Select Fund I-A, L.P. (\"USVP Select\") and has sole voting and dispositive power with respect to the shares held by USVP Select."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person, Richard W. Lewis, Jonathan D. Root and Dafina Toncheva are the managing members of PMG Select and share voting and dispositive power with respect to the shares held by USVP Select. Each of the managing members of PMG XII and PMG Select disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Consists of (i) 1,043,988 shares of Common Stock underlying Series C Preferred Stock, 496,309 shares of Common Stock underlying Series D Preferred Stock and 146,106 shares of Common Stock underlying Series E Preferred Stock held by USVP XII; (ii) 52,983 shares of Common Stock underlying Series C Preferred Stock, 25,189 shares of Common Stock underlying Series D Preferred Stock, and 7,415 shares of Common Stock underlying Series E Preferred Stock held by USVP XII-A; and (iii) 921,131 shares of Common Stock underlying Series E Preferred Stock held by U.S. Venture Partners Select Fund I, L.P. on its own behalf and as a nominee for USVP Select."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1096971},"source":{"system":"sec-edgar","filing":"0001641172-25-022252","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000164117225022252/ownership.xml","form_type":"4"}},{"id":1074429,"issuer":{"id":5607,"kind":"organization","name":"SHOULDER INNOVATIONS, INC.","symbol":"SI"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-05T20:05:09.000Z","date":"2025-08-01","kind":"purchase","planned":false,"acquired":true,"shares":40000,"price":15,"value":600000.0,"ownership":{"direct":true},"balance_after":47666,"source":{"system":"sec-edgar","filing":"0001641172-25-022252","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000164117225022252/ownership.xml","form_type":"4"}},{"id":1074428,"issuer":{"id":5607,"kind":"organization","name":"SHOULDER INNOVATIONS, INC.","symbol":"SI"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-05T20:05:09.000Z","date":"2025-08-01","kind":"grant","planned":false,"acquired":true,"shares":7666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents an award of restricted stock units (\"RSUs\"). The RSUs will vest on the earlier of the date of the annual meeting of stockholders to be held in 2026 or August 1, 2026. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date."}],"balance_after":7666,"source":{"system":"sec-edgar","filing":"0001641172-25-022252","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000164117225022252/ownership.xml","form_type":"4"}},{"id":1074427,"issuer":{"id":5607,"kind":"organization","name":"SHOULDER INNOVATIONS, INC.","symbol":"SI"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-05T20:05:09.000Z","date":"2025-08-01","kind":"exercise","planned":false,"acquired":true,"shares":921131,"ownership":{"direct":false,"nature":"By U.S. Venture Partners Select Fund I-A, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group XII, L.L.C. (\"PMG XII\") is the general partner of U.S. Venture Partners XII, L.P. (\"USVP XII\") and U.S. Venture Partners XII-A, L.P (\"USVP XII-A\") and has sole voting and dispositive power with respect to the shares held by USVP XII and USVP XII-A. The Reporting Person, Steven M. Krausz, Richard W. Lewis, Jonathan D. Root and Dafina Toncheva are the managing members of PMG XII, and share voting and dispositive power with respect to the shares held by USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C. (\"PMG Select\") is the general partner of U.S. Venture Partners Select Fund I-A, L.P. (\"USVP Select\") and has sole voting and dispositive power with respect to the shares held by USVP Select."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person, Richard W. Lewis, Jonathan D. Root and Dafina Toncheva are the managing members of PMG Select and share voting and dispositive power with respect to the shares held by USVP Select. Each of the managing members of PMG XII and PMG Select disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares."}],"balance_after":921131,"source":{"system":"sec-edgar","filing":"0001641172-25-022252","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000164117225022252/ownership.xml","form_type":"4"}},{"id":1074426,"issuer":{"id":5607,"kind":"organization","name":"SHOULDER INNOVATIONS, INC.","symbol":"SI"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-05T20:05:09.000Z","date":"2025-08-01","kind":"exercise","planned":false,"acquired":true,"shares":85587,"ownership":{"direct":false,"nature":"By U.S. Venture Partners XII-A, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group XII, L.L.C. (\"PMG XII\") is the general partner of U.S. Venture Partners XII, L.P. (\"USVP XII\") and U.S. Venture Partners XII-A, L.P (\"USVP XII-A\") and has sole voting and dispositive power with respect to the shares held by USVP XII and USVP XII-A. The Reporting Person, Steven M. Krausz, Richard W. Lewis, Jonathan D. Root and Dafina Toncheva are the managing members of PMG XII, and share voting and dispositive power with respect to the shares held by USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C. (\"PMG Select\") is the general partner of U.S. Venture Partners Select Fund I-A, L.P. (\"USVP Select\") and has sole voting and dispositive power with respect to the shares held by USVP Select."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person, Richard W. Lewis, Jonathan D. Root and Dafina Toncheva are the managing members of PMG Select and share voting and dispositive power with respect to the shares held by USVP Select. Each of the managing members of PMG XII and PMG Select disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares."}],"balance_after":85587,"source":{"system":"sec-edgar","filing":"0001641172-25-022252","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000164117225022252/ownership.xml","form_type":"4"}},{"id":1074425,"issuer":{"id":5607,"kind":"organization","name":"SHOULDER INNOVATIONS, INC.","symbol":"SI"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-08-05T20:05:09.000Z","date":"2025-08-01","kind":"exercise","planned":false,"acquired":true,"shares":1686403,"ownership":{"direct":false,"nature":"By U.S. Venture Partners XII, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Immediately prior to the closing of the Issuer's initial public offering, the shares of preferred stock of the Issuer automatically converted into shares of Common Stock on a one-for-0.052410901 basis."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group XII, L.L.C. (\"PMG XII\") is the general partner of U.S. Venture Partners XII, L.P. (\"USVP XII\") and U.S. Venture Partners XII-A, L.P (\"USVP XII-A\") and has sole voting and dispositive power with respect to the shares held by USVP XII and USVP XII-A. The Reporting Person, Steven M. Krausz, Richard W. Lewis, Jonathan D. Root and Dafina Toncheva are the managing members of PMG XII, and share voting and dispositive power with respect to the shares held by USVP XII and USVP XII-A. Presidio Management Group Select Fund I, L.L.C. (\"PMG Select\") is the general partner of U.S. Venture Partners Select Fund I-A, L.P. (\"USVP Select\") and has sole voting and dispositive power with respect to the shares held by USVP Select."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The Reporting Person, Richard W. Lewis, Jonathan D. Root and Dafina Toncheva are the managing members of PMG Select and share voting and dispositive power with respect to the shares held by USVP Select. Each of the managing members of PMG XII and PMG Select disclaims beneficial ownership of such holdings, except to the extent of their pecuniary interest in the shares."}],"balance_after":1686403,"source":{"system":"sec-edgar","filing":"0001641172-25-022252","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000164117225022252/ownership.xml","form_type":"4"}},{"id":1082203,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Preferred Series C Stock","published_at":"2025-07-25T00:47:16.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":false,"shares":1117743,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\", and together with USVP XII, the \"USVP XII Funds\"). Presidio Management Group Select Fund I, L.L.C (\"PMG SFI\", and, together with USVP XII, USVP XII-A, U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\"), U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\"), and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. PMG XII and PMG SFI may be deemed to share voting and dispositive power over the stock held by USVP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Jonathan D. Root, Richard W. Lewis, Dafina Toncheva and Steven M. Krausz, are managing members of PMG XII, who may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds.  Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Stock held by USVP SFI, on its own behalf and as nominee for USVP SFI-A."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1117743},"source":{"system":"sec-edgar","filing":"0001415889-25-020276","document":"form4-07252025_120712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000141588925020276/form4-07252025_120712.xml","form_type":"4"}},{"id":1082202,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Preferred Series C Stock","published_at":"2025-07-25T00:47:16.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":false,"shares":26993,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\", and together with USVP XII, the \"USVP XII Funds\"). Presidio Management Group Select Fund I, L.L.C (\"PMG SFI\", and, together with USVP XII, USVP XII-A, U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\"), U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\"), and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. PMG XII and PMG SFI may be deemed to share voting and dispositive power over the stock held by USVP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Jonathan D. Root, Richard W. Lewis, Dafina Toncheva and Steven M. Krausz, are managing members of PMG XII, who may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds.  Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Stock Held by USVP XII-A."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":26993},"source":{"system":"sec-edgar","filing":"0001415889-25-020276","document":"form4-07252025_120712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000141588925020276/form4-07252025_120712.xml","form_type":"4"}},{"id":1082201,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Preferred Stock Series B","published_at":"2025-07-25T00:47:16.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":false,"shares":41876,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\", and together with USVP XII, the \"USVP XII Funds\"). Presidio Management Group Select Fund I, L.L.C (\"PMG SFI\", and, together with USVP XII, USVP XII-A, U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\"), U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\"), and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. PMG XII and PMG SFI may be deemed to share voting and dispositive power over the stock held by USVP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Jonathan D. Root, Richard W. Lewis, Dafina Toncheva and Steven M. Krausz, are managing members of PMG XII, who may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds.  Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Stock Held by USVP XII-A."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":41876},"source":{"system":"sec-edgar","filing":"0001415889-25-020276","document":"form4-07252025_120712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000141588925020276/form4-07252025_120712.xml","form_type":"4"}},{"id":1082200,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Preferred Series A Stock","published_at":"2025-07-25T00:47:16.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":false,"shares":149655,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\", and together with USVP XII, the \"USVP XII Funds\"). Presidio Management Group Select Fund I, L.L.C (\"PMG SFI\", and, together with USVP XII, USVP XII-A, U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\"), U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\"), and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. PMG XII and PMG SFI may be deemed to share voting and dispositive power over the stock held by USVP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Jonathan D. Root, Richard W. Lewis, Dafina Toncheva and Steven M. Krausz, are managing members of PMG XII, who may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds.  Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Stock Held by USVP XII-A."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":149655},"source":{"system":"sec-edgar","filing":"0001415889-25-020276","document":"form4-07252025_120712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000141588925020276/form4-07252025_120712.xml","form_type":"4"}},{"id":1082199,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Preferred Series C Stock","published_at":"2025-07-25T00:47:16.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":false,"shares":531877,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Stock held by U.S. Venture Partners XII, L.P. (\"USVP XII\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\", and together with USVP XII, the \"USVP XII Funds\"). Presidio Management Group Select Fund I, L.L.C (\"PMG SFI\", and, together with USVP XII, USVP XII-A, U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\"), U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\"), and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. PMG XII and PMG SFI may be deemed to share voting and dispositive power over the stock held by USVP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Jonathan D. Root, Richard W. Lewis, Dafina Toncheva and Steven M. Krausz, are managing members of PMG XII, who may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds.  Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":531877},"source":{"system":"sec-edgar","filing":"0001415889-25-020276","document":"form4-07252025_120712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000141588925020276/form4-07252025_120712.xml","form_type":"4"}},{"id":1082198,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Preferred Series B Stock","published_at":"2025-07-25T00:47:16.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":false,"shares":825135,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Stock held by U.S. Venture Partners XII, L.P. (\"USVP XII\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\", and together with USVP XII, the \"USVP XII Funds\"). Presidio Management Group Select Fund I, L.L.C (\"PMG SFI\", and, together with USVP XII, USVP XII-A, U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\"), U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\"), and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. PMG XII and PMG SFI may be deemed to share voting and dispositive power over the stock held by USVP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Jonathan D. Root, Richard W. Lewis, Dafina Toncheva and Steven M. Krausz, are managing members of PMG XII, who may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds.  Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":825135},"source":{"system":"sec-edgar","filing":"0001415889-25-020276","document":"form4-07252025_120712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000141588925020276/form4-07252025_120712.xml","form_type":"4"}},{"id":1082197,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Preferred Series A Stock","published_at":"2025-07-25T00:47:16.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":false,"shares":2948794,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See footnotes"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Stock held by U.S. Venture Partners XII, L.P. (\"USVP XII\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\", and together with USVP XII, the \"USVP XII Funds\"). Presidio Management Group Select Fund I, L.L.C (\"PMG SFI\", and, together with USVP XII, USVP XII-A, U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\"), U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\"), and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. PMG XII and PMG SFI may be deemed to share voting and dispositive power over the stock held by USVP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Jonathan D. Root, Richard W. Lewis, Dafina Toncheva and Steven M. Krausz, are managing members of PMG XII, who may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds.  Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2948794},"source":{"system":"sec-edgar","filing":"0001415889-25-020276","document":"form4-07252025_120712.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000141588925020276/form4-07252025_120712.xml","form_type":"4"}},{"id":1082196,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-25T00:47:16.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":true,"shares":1117743,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\", and together with USVP XII, the \"USVP XII Funds\"). Presidio Management Group Select Fund I, L.L.C (\"PMG SFI\", and, together with USVP XII, USVP XII-A, U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\"), U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\"), and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. PMG XII and PMG SFI may be deemed to share voting and dispositive power over the stock held by USVP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Jonathan D. Root, Richard W. Lewis, Dafina Toncheva and Steven M. Krausz, are managing members of PMG XII, who may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds.  Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"Stock held by USVP SFI, on its own behalf and as nominee for USVP SFI-A."}],"balance_after":1117743,"source":{"system":"sec-edgar","filing":"0001415889-25-020276","document":"form4-07252025_120712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000141588925020276/form4-07252025_120712.xml","form_type":"4"}},{"id":1082195,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-25T00:47:16.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":true,"shares":26993,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\", and together with USVP XII, the \"USVP XII Funds\"). Presidio Management Group Select Fund I, L.L.C (\"PMG SFI\", and, together with USVP XII, USVP XII-A, U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\"), U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\"), and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. PMG XII and PMG SFI may be deemed to share voting and dispositive power over the stock held by USVP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Jonathan D. Root, Richard W. Lewis, Dafina Toncheva and Steven M. Krausz, are managing members of PMG XII, who may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds.  Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Stock Held by USVP XII-A."}],"balance_after":218524,"source":{"system":"sec-edgar","filing":"0001415889-25-020276","document":"form4-07252025_120712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000141588925020276/form4-07252025_120712.xml","form_type":"4"}},{"id":1082194,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-25T00:47:16.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":true,"shares":41876,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\", and together with USVP XII, the \"USVP XII Funds\"). Presidio Management Group Select Fund I, L.L.C (\"PMG SFI\", and, together with USVP XII, USVP XII-A, U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\"), U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\"), and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. PMG XII and PMG SFI may be deemed to share voting and dispositive power over the stock held by USVP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Jonathan D. Root, Richard W. Lewis, Dafina Toncheva and Steven M. Krausz, are managing members of PMG XII, who may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds.  Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Stock Held by USVP XII-A."}],"balance_after":191531,"source":{"system":"sec-edgar","filing":"0001415889-25-020276","document":"form4-07252025_120712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000141588925020276/form4-07252025_120712.xml","form_type":"4"}},{"id":1082193,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-25T00:47:16.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":true,"shares":149655,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\", and together with USVP XII, the \"USVP XII Funds\"). Presidio Management Group Select Fund I, L.L.C (\"PMG SFI\", and, together with USVP XII, USVP XII-A, U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\"), U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\"), and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. PMG XII and PMG SFI may be deemed to share voting and dispositive power over the stock held by USVP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Jonathan D. Root, Richard W. Lewis, Dafina Toncheva and Steven M. Krausz, are managing members of PMG XII, who may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds.  Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"Stock Held by USVP XII-A."}],"balance_after":149655,"source":{"system":"sec-edgar","filing":"0001415889-25-020276","document":"form4-07252025_120712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000141588925020276/form4-07252025_120712.xml","form_type":"4"}},{"id":1082192,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-25T00:47:16.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":true,"shares":531877,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Stock held by U.S. Venture Partners XII, L.P. (\"USVP XII\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\", and together with USVP XII, the \"USVP XII Funds\"). Presidio Management Group Select Fund I, L.L.C (\"PMG SFI\", and, together with USVP XII, USVP XII-A, U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\"), U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\"), and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. PMG XII and PMG SFI may be deemed to share voting and dispositive power over the stock held by USVP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Jonathan D. Root, Richard W. Lewis, Dafina Toncheva and Steven M. Krausz, are managing members of PMG XII, who may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds.  Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein."}],"balance_after":4305806,"source":{"system":"sec-edgar","filing":"0001415889-25-020276","document":"form4-07252025_120712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000141588925020276/form4-07252025_120712.xml","form_type":"4"}},{"id":1082191,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-25T00:47:16.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":true,"shares":825135,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Stock held by U.S. Venture Partners XII, L.P. (\"USVP XII\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\", and together with USVP XII, the \"USVP XII Funds\"). Presidio Management Group Select Fund I, L.L.C (\"PMG SFI\", and, together with USVP XII, USVP XII-A, U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\"), U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\"), and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. PMG XII and PMG SFI may be deemed to share voting and dispositive power over the stock held by USVP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Jonathan D. Root, Richard W. Lewis, Dafina Toncheva and Steven M. Krausz, are managing members of PMG XII, who may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds.  Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein."}],"balance_after":3773929,"source":{"system":"sec-edgar","filing":"0001415889-25-020276","document":"form4-07252025_120712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000141588925020276/form4-07252025_120712.xml","form_type":"4"}},{"id":1082190,"issuer":{"id":5551,"kind":"organization","name":"CARLSMED, INC.","symbol":"CARL"},"owners":[{"id":47690,"kind":"organization","name":"Presidio Management Group XII, L.L.C.","position":1,"cik":"0001734820","reported_name":"Presidio Management Group XII, L.L.C.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":49117,"kind":"organization","name":"U.S. Venture Partners XII, L.P.","position":2,"cik":"0001734819","reported_name":"U.S. Venture Partners XII, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":3,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-07-25T00:47:16.000Z","date":"2025-07-24","kind":"exercise","planned":false,"acquired":true,"shares":2948794,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"These shares of preferred stock are reported after giving effect to the 1-for-5.58 reverse split of the Issuer's common and preferred stock effected on July 10, 2025 (the \"Reverse Split\"). Each share of Series A Preferred Stock, Series B Preferred Stock, and Series C Preferred Stock is convertible into one share of the Issuer's common stock immediately prior to the closing of the Issuer's initial public offering. These shares are reported in Table II above on an as-converted 1-to-1 basis with no additional consideration and have no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Stock held by U.S. Venture Partners XII, L.P. (\"USVP XII\")."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Presidio Management Group XII, L.L.C (\"PMG XII\") is the general partner of USVP XII and U.S. Venture Partners XII-A, L.P. (\"USVP XII-A\", and together with USVP XII, the \"USVP XII Funds\"). Presidio Management Group Select Fund I, L.L.C (\"PMG SFI\", and, together with USVP XII, USVP XII-A, U.S. Venture Partners Select Fund I, L.P. (\"USVP SFI\"), U.S. Venture Partners Select Fund I-A, L.P. (\"USVP SFI-A\"), and PMG XII, \"USVP\") is the general partner of USVP SFI and USVP SFI-A. PMG XII and PMG SFI may be deemed to share voting and dispositive power over the stock held by USVP."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Each of Jonathan D. Root, Richard W. Lewis, Dafina Toncheva and Steven M. Krausz, are managing members of PMG XII, who may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds. In addition, Casey M. Tansey is the managing partner of PMG XII and may be deemed to share voting and dispositive power over the reported securities held by the USVP XII Funds.  Each such persons and entities disclaim beneficial ownership of the reported securities held by the USVP XII Funds, except to the extent of any pecuniary interest therein."}],"balance_after":2948794,"source":{"system":"sec-edgar","filing":"0001415889-25-020276","document":"form4-07252025_120712.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1734820/000141588925020276/form4-07252025_120712.xml","form_type":"4"}},{"id":1086483,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-16T20:07:24.000Z","date":"2025-07-15","kind":"grant","planned":false,"acquired":true,"shares":133,"price":128,"value":17024.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy."}],"balance_after":22014,"source":{"system":"sec-edgar","filing":"0001104659-25-068328","document":"tm2521079-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465925068328/tm2521079-3_4seq1.xml","form_type":"4"}},{"id":1159157,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-05-05T23:26:37.000Z","date":"2025-05-01","kind":"grant","planned":false,"acquired":true,"shares":1266,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date."}],"balance_after":21881,"source":{"system":"sec-edgar","filing":"0001104659-25-044669","document":"tm2514079-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465925044669/tm2514079-3_4seq1.xml","form_type":"4"}},{"id":1170984,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-04-16T20:08:34.000Z","date":"2025-04-14","kind":"grant","planned":false,"acquired":true,"shares":103,"price":149.7,"value":15419.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy."}],"balance_after":20615,"source":{"system":"sec-edgar","filing":"0001104659-25-035499","document":"tm2512484-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465925035499/tm2512484-4_4seq1.xml","form_type":"4"}},{"id":1300058,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-01-18T01:15:56.000Z","date":"2025-01-15","kind":"grant","planned":false,"acquired":true,"shares":81,"price":176.33,"value":14282.73,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy."}],"balance_after":20512,"source":{"system":"sec-edgar","filing":"0001104659-25-004600","document":"tm253739-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465925004600/tm253739-1_4seq1.xml","form_type":"4"}},{"id":1385863,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-10-16T20:23:25.000Z","date":"2024-10-14","kind":"grant","planned":false,"acquired":true,"shares":68,"price":210.46,"value":14311.28,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy."}],"balance_after":20431,"source":{"system":"sec-edgar","filing":"0001104659-24-109201","document":"tm2426283-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465924109201/tm2426283-4_4seq1.xml","form_type":"4"}},{"id":1452567,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-07-17T21:09:03.000Z","date":"2024-07-15","kind":"grant","planned":false,"acquired":true,"shares":103,"price":138.58,"value":14273.74,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy."}],"balance_after":20363,"source":{"system":"sec-edgar","filing":"0001104659-24-080587","document":"tm2419668-5_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465924080587/tm2419668-5_4seq1.xml","form_type":"4"}},{"id":1526323,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-06T22:23:54.000Z","date":"2024-05-02","kind":"grant","planned":false,"acquired":true,"shares":716,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date."}],"balance_after":20260,"source":{"system":"sec-edgar","filing":"0001104659-24-057572","document":"tm2413647-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465924057572/tm2413647-7_4seq1.xml","form_type":"4"}},{"id":1541167,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-04-16T21:17:28.000Z","date":"2024-04-12","kind":"grant","planned":false,"acquired":true,"shares":62,"price":231.74,"value":14367.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy."}],"balance_after":19544,"source":{"system":"sec-edgar","filing":"0001104659-24-047892","document":"tm2411955-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465924047892/tm2411955-4_4seq1.xml","form_type":"4"}},{"id":1676360,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-19T01:43:45.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":77,"price":186.1,"value":14329.7,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares of Common Stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy."}],"balance_after":19482,"source":{"system":"sec-edgar","filing":"0001104659-24-004906","document":"tm243653-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465924004906/tm243653-1_4seq1.xml","form_type":"4"}},{"id":1676359,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-19T01:43:45.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":8,"price":150.47,"value":1203.76,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"Represents settlement of shares of Common Stock issued in lieu of cash fees to which the Reporting Person was previously granted pursuant to the Company's Non-Employee Director Compensation Policy in respect of compensation for the third quarter of 2023 and inadvertently not previously issued due to a clerical error."}],"balance_after":19405,"source":{"system":"sec-edgar","filing":"0001104659-24-004906","document":"tm243653-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465924004906/tm243653-1_4seq1.xml","form_type":"4"}},{"id":1676358,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-19T01:43:45.000Z","date":"2024-01-16","kind":"grant","planned":false,"acquired":true,"shares":2,"price":325.91,"value":651.82,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents settlement of shares of Common Stock issued in lieu of cash fees to which the Reporting Person was previously granted pursuant to the Company's Non-Employee Director Compensation Policy in respect of compensation for the second quarter of 2023 and inadvertently not previously issued due to a clerical error."}],"balance_after":19397,"source":{"system":"sec-edgar","filing":"0001104659-24-004906","document":"tm243653-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465924004906/tm243653-1_4seq1.xml","form_type":"4"}},{"id":1676357,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-19T01:43:45.000Z","date":"2023-08-25","kind":"gift","planned":false,"acquired":true,"shares":500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Securities held by The Kylie Tansey Irrevocable Trust."}],"balance_after":500,"source":{"system":"sec-edgar","filing":"0001104659-24-004906","document":"tm243653-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465924004906/tm243653-1_4seq1.xml","form_type":"4"}},{"id":1676356,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-19T01:43:45.000Z","date":"2023-08-25","kind":"gift","planned":false,"acquired":true,"shares":500,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"By Family Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Securities held by The Kimberly Tansey Irrevocable Trust."}],"balance_after":500,"source":{"system":"sec-edgar","filing":"0001104659-24-004906","document":"tm243653-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465924004906/tm243653-1_4seq1.xml","form_type":"4"}},{"id":1676355,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-19T01:43:45.000Z","date":"2023-08-25","kind":"gift","planned":false,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19395,"source":{"system":"sec-edgar","filing":"0001104659-24-004906","document":"tm243653-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465924004906/tm243653-1_4seq1.xml","form_type":"4"}},{"id":1676354,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-01-19T01:43:45.000Z","date":"2023-08-25","kind":"gift","planned":false,"acquired":false,"shares":500,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":19895,"source":{"system":"sec-edgar","filing":"0001104659-24-004906","document":"tm243653-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465924004906/tm243653-1_4seq1.xml","form_type":"4"}},{"id":1758978,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-10-17T23:49:18.000Z","date":"2023-10-13","kind":"grant","planned":false,"acquired":true,"shares":87,"price":150.47,"value":13090.89,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy"}],"balance_after":20395,"source":{"system":"sec-edgar","filing":"0001104659-23-109695","document":"tm2328548-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465923109695/tm2328548-4_4seq1.xml","form_type":"4"}},{"id":1826843,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-07-19T20:52:42.000Z","date":"2023-07-17","kind":"grant","planned":false,"acquired":true,"shares":40,"price":325.91,"value":13036.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy."}],"balance_after":20308,"source":{"system":"sec-edgar","filing":"0001104659-23-082383","document":"tm2321602-7_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465923082383/tm2321602-7_4seq1.xml","form_type":"4"}},{"id":1910130,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-05-01T23:50:09.000Z","date":"2023-04-27","kind":"grant","planned":false,"acquired":true,"shares":669,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of Restricted Stock Units (\"RSUs\"). Each RSU represents a contingent right to receive one share of common stock. The RSUs shall vest upon the earlier to occur of (a) the first anniversary of the date of grant or (b) the date that is immediately prior to the occurrence of a Change of Control (as defined in the Issuer's 2018 Incentive Award Plan), in each case subject to the Reporting Person's continued employment with the Issuer through the applicable vesting date."}],"balance_after":20268,"source":{"system":"sec-edgar","filing":"0001104659-23-054648","document":"tm2314266-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465923054648/tm2314266-6_4seq1.xml","form_type":"4"}},{"id":1920955,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-04-12T20:11:10.000Z","date":"2023-04-10","kind":"grant","planned":false,"acquired":true,"shares":56,"price":231.77,"value":12979.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy."}],"balance_after":19599,"source":{"system":"sec-edgar","filing":"0001104659-23-044585","document":"tm2312581-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465923044585/tm2312581-6_4seq1.xml","form_type":"4"}},{"id":2050818,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-01-20T00:53:04.000Z","date":"2023-01-10","kind":"grant","acquired":true,"shares":52,"price":248.31,"value":12912.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of cash fees pursuant to the Company's Non-Employee Director Compensation Policy."}],"balance_after":19543,"source":{"system":"sec-edgar","filing":"0001104659-23-005111","document":"tm233800-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465923005111/tm233800-1_4seq1.xml","form_type":"4"}},{"id":2137659,"issuer":{"id":1186,"kind":"organization","name":"Inspire Medical Systems, Inc.","symbol":"INSP"},"owners":[{"id":21218,"kind":"person","name":"Tansey Casey M","position":1,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-10-13T20:19:17.000Z","date":"2022-10-11","kind":"grant","acquired":true,"shares":81,"price":168.98,"value":13687.38,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock received in lieu of cash fees pursuant to the Issuer's Non-Employee Director Compensation Policy."}],"balance_after":19491,"source":{"system":"sec-edgar","filing":"0001104659-22-108499","document":"tm2228171-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1609550/000110465922108499/tm2228171-2_4seq1.xml","form_type":"4"}},{"id":2195686,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-03T21:58:50.000Z","date":"2022-08-03","kind":"sale","acquired":false,"shares":1796,"price":0.804,"value":1443.984,"ownership":{"direct":false,"nature":"Directly owned by AFF X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.77 to $0.81, inclusive for sales on 8/1/22; prices ranging from $0.78 to $0.83, inclusive for sales on 8/2/22; and prices ranging from $0.79 to $0.83, inclusive for sales on 8/3/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":127569,"source":{"system":"sec-edgar","filing":"0001062993-22-017215","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322017215/form4.xml","form_type":"4"}},{"id":2195685,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-03T21:58:50.000Z","date":"2022-08-03","kind":"sale","acquired":false,"shares":57580,"price":0.804,"value":46294.32,"ownership":{"direct":false,"nature":"Directly owned by USVP X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.77 to $0.81, inclusive for sales on 8/1/22; prices ranging from $0.78 to $0.83, inclusive for sales on 8/2/22; and prices ranging from $0.79 to $0.83, inclusive for sales on 8/3/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":3981940,"source":{"system":"sec-edgar","filing":"0001062993-22-017215","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322017215/form4.xml","form_type":"4"}},{"id":2195684,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-03T21:58:50.000Z","date":"2022-08-02","kind":"sale","acquired":false,"shares":853,"price":0.797,"value":679.841,"ownership":{"direct":false,"nature":"Directly owned by AFF X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.77 to $0.81, inclusive for sales on 8/1/22; prices ranging from $0.78 to $0.83, inclusive for sales on 8/2/22; and prices ranging from $0.79 to $0.83, inclusive for sales on 8/3/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":129365,"source":{"system":"sec-edgar","filing":"0001062993-22-017215","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322017215/form4.xml","form_type":"4"}},{"id":2195683,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-03T21:58:50.000Z","date":"2022-08-02","kind":"sale","acquired":false,"shares":27348,"price":0.797,"value":21796.356,"ownership":{"direct":false,"nature":"Directly owned by USVP X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.77 to $0.81, inclusive for sales on 8/1/22; prices ranging from $0.78 to $0.83, inclusive for sales on 8/2/22; and prices ranging from $0.79 to $0.83, inclusive for sales on 8/3/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":4039520,"source":{"system":"sec-edgar","filing":"0001062993-22-017215","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322017215/form4.xml","form_type":"4"}},{"id":2195682,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-03T21:58:50.000Z","date":"2022-08-01","kind":"sale","acquired":false,"shares":807,"price":0.786,"value":634.302,"ownership":{"direct":false,"nature":"Directly owned by AFF X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.77 to $0.81, inclusive for sales on 8/1/22; prices ranging from $0.78 to $0.83, inclusive for sales on 8/2/22; and prices ranging from $0.79 to $0.83, inclusive for sales on 8/3/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":130218,"source":{"system":"sec-edgar","filing":"0001062993-22-017215","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322017215/form4.xml","form_type":"4"}},{"id":2195681,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-08-03T21:58:50.000Z","date":"2022-08-01","kind":"sale","acquired":false,"shares":25896,"price":0.786,"value":20354.256,"ownership":{"direct":false,"nature":"Directly owned by USVP X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.77 to $0.81, inclusive for sales on 8/1/22; prices ranging from $0.78 to $0.83, inclusive for sales on 8/2/22; and prices ranging from $0.79 to $0.83, inclusive for sales on 8/3/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":4066868,"source":{"system":"sec-edgar","filing":"0001062993-22-017215","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322017215/form4.xml","form_type":"4"}},{"id":2200179,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-30T00:54:43.000Z","date":"2022-07-28","kind":"sale","acquired":false,"shares":984,"price":0.892,"value":877.728,"ownership":{"direct":false,"nature":"Directly owned by AFF X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.89 to $0.91, inclusive for sales on 7/28/22. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":131025,"source":{"system":"sec-edgar","filing":"0001062993-22-016924","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322016924/form4.xml","form_type":"4"}},{"id":2200178,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-30T00:54:43.000Z","date":"2022-07-28","kind":"sale","acquired":false,"shares":31533,"price":0.892,"value":28127.436,"ownership":{"direct":false,"nature":"Directly owned by USVP X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.89 to $0.91, inclusive for sales on 7/28/22. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":4092764,"source":{"system":"sec-edgar","filing":"0001062993-22-016924","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322016924/form4.xml","form_type":"4"}},{"id":2201315,"issuer":{"id":89916,"kind":"organization","name":"eFFECTOR Therapeutics, Inc.","symbol":"EFTR"},"owners":[{"id":124931,"kind":"organization","name":"Presidio Management Group X LLC","position":1,"cik":"0001602744","reported_name":"Presidio Management Group X LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124932,"kind":"organization","name":"US VENTURE PARTNERS X LP","position":2,"cik":"0001440514","reported_name":"US VENTURE PARTNERS X LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":124933,"kind":"organization","name":"USVP X AFFILIATES LP","position":3,"cik":"0001453359","reported_name":"USVP X AFFILIATES LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":21218,"kind":"person","name":"Tansey Casey M","position":4,"cik":"0001474322","reported_name":"Tansey Casey M","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":29762,"kind":"person","name":"ROOT JONATHAN D","position":5,"cik":"0001225480","reported_name":"ROOT JONATHAN D","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-07-27T22:20:11.000Z","date":"2022-07-27","kind":"sale","acquired":false,"shares":1321,"price":0.892,"value":1178.332,"ownership":{"direct":false,"nature":"Directly owned by AFF X"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $0.91 to $0.95, inclusive for sales on 7/25/22; prices ranging from $0.90 to $0.91, inclusive for sales on 7/26/22; and prices ranging from $0.89 to $0.91, inclusive for sales on 7/27/22;. The reporting persons undertake to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Presidio Management Group X, L.L.C. (\"PMG X\"), the general partner of each of U.S. Venture Partners X, L.P. (\"USVP X\") and USVP X Affiliates L.P. (\"AFF X\") (together, the \"USVP X Funds\"), has sole voting and dispositive power with respect to the shares held by the USVP X Funds. Jonathan Root is a managing member of PMG X with additional rights with respect to the Issuer's securities, and may be deemed to have sole voting and dispositive power with respect to the shares. Casey Tansey is the sole managing partner of PMG X and may be deemed to have sole dispositive power over the reported securities held by the USVP X Funds and may be deemed to have shared voting power over the reported securities held by the USVP X Funds. Each of the foregoing persons disclaims beneficial ownership of such securities, except to the extent of any pecuniary interest therein."}],"balance_after":132009,"source":{"system":"sec-edgar","filing":"0001062993-22-016802","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1474322/000106299322016802/form4.xml","form_type":"4"}}],"next_cursor":"2022-07-27T22:20:11.000000Z,2201315"}